OVERVIEW

Improving PBC Outcomes by Prioritizing Patients' Needs is organized by Springer Healthcare IME.

Overview
Patients with PBC commonly experience a significant symptom burden, including fatigue and pruritus. Despite the existence of tools that comprehensively evaluate these, under-recognition and inconsistent management persist, emphasizing the need for regular assessment and improved symptom management to enhance the quality of life for patients.

In the evolving landscape of PBC, personalized care is paramount. Early risk assessment, timely incorporation of second-line treatments, and the exploration of innovative therapies are shaping the future of this disorder. This multi-faceted program disseminates the latest news and cutting-edge data on PBC treatment to arm HCPs with the latest information to optimize patients’ outcomes.

Learning Objectives:

Following completion of this independent educational program, you will be able to:

• Describe how to manage and regularly monitor symptoms of PBC, recognizing that symptom burden does not correlate with disease severity

• Explain the importance of a patient-centric approach to the management of PBC, prioritizing symptom management and quality of life (QoL) rather than a sole focus on biochemical indices

• Analyse and apply the most recent advances in the management and treatment of PBC

Program components

Conference coverage: Keeping up to date with the latest news and highlights from key congresses is vital if healthcare practitioners are to keep abreast of the latest clinical developments in their field. The Liver Meeting is “committed to educating Congress and key federal officials on the growing burden of liver disease, to inform policies that support research and treatment of hepatic disorders.” Considering this, we have summarised the most relevant content from the meeting into five articles, complemented by three short videos taken onsite at this years’ Liver Meeting, featuring leading experts interpreting the very latest clinical data.

Our coverage focusses on key highlights from The Liver Meeting, allowing those who did attend or those that would like to read more about this, seek supplementary and reinforcing analysis from leading experts in the field as it breaks and with this information published just 48 hours after the initial data release.

Clinical perspectives: Watch our three leading experts, Dr Gideon Hirschfield, Dr Palak Trivedi and Dr Marlyn Mayo, as they discuss a broader analysis of the data presented at The Liver Meeting. Our clinical perspectives videos debate the latest data placing it into the wider context of the current treatment landscape. Here we explore the implications of this data for future clinical practice and how HCP’s might approach its implementation.

Join us as we discuss

The key highlights from The Liver Meeting
The current and ongoing unmet needs for patients and the clinical burden of PBC
What we can look forward to in 2024 and where the field is headed

Target audience
This independent educational program is suitable for Global hepatologists and gastroenterologists, but will be of interest to all members of the multidisciplinary team that manages PBC patients.

This program is made possible thanks to an independent educational grant from Ipsen.